Horizon Therapeutics Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
2,190
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$27.8B
Horizon Therapeutics General Information
Description
Developer of drug therapies intended to deliver medicines for rare, autoimmune, and severe inflammatory diseases. The company is focused on discovering, developing, and commercializing medicines to address the needs of people impacted by rare, autoimmune, and severe inflammatory diseases, enabling medical staff to supply critical medicine for treating autoimmune diseases.
Contact Information
Website
www.horizontherapeutics.comCorporate Office
- 70 Street Stephens Green
- Saint Kevin's
- Dublin D02 E2X4
- Ireland
Corporate Office
- 70 Street Stephens Green
- Saint Kevin's
- Dublin D02 E2X4
- Ireland
Horizon Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 19. Merger/Acquisition | 06-Oct-2023 | $27.8B | Completed | Profitable | ||
| 18. Debt - Acquisition | 26-Feb-2021 | Completed | Generating Revenue | |||
| 17. Debt Refinancing | 16-Dec-2019 | Completed | Generating Revenue | |||
| 16. Debt Refinancing | 11-Jul-2019 | Completed | Generating Revenue | |||
| 15. Debt Refinancing | 17-May-2019 | Completed | Generating Revenue | |||
| 14. Debt Refinancing | 17-Oct-2018 | Completed | Generating Revenue | |||
| 13. Debt Refinancing | 17-Oct-2017 | Completed | Generating Revenue | |||
| 12. Debt Refinancing | 23-Mar-2017 | Completed | Generating Revenue | |||
| 11. Debt - Acquisition | 13-Oct-2016 | $675M | $334M | Completed | Generating Revenue | |
| 10. Merger/Acquisition | 27-Jun-2016 | Cancelled | Generating Revenue |
Horizon Therapeutics Comparisons
Industry
Financing
Details
Horizon Therapeutics Competitors (56)
One of Horizon Therapeutics’s 56 competitors is Crinetics Pharmaceuticals, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Crinetics Pharmaceuticals | Formerly VC-backed | San Diego, CA | ||||
| Santhera Pharmaceuticals | Private Debt Financed | Pratteln, Switzerland | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Arcturus Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| XBiotech | Corporation | Austin, TX |
Horizon Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Horizon Therapeutics Patents
Horizon Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-7598522-B2 | Aroma management system | Active | 16-Jun-2022 | ||
| AU-2021324665-A1 | Methods of treating gout | Pending | 10-Aug-2020 | ||
| CA-3189100-A1 | Methods of treating gout | Pending | 10-Aug-2020 | ||
| EP-4192581-A1 | Methods of treating gout | Pending | 10-Aug-2020 | ||
| EP-4192581-A4 | Methods of treating gout | Pending | 10-Aug-2020 | A61K31/519 |
Horizon Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Horizon Therapeutics Former Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Athyrium Capital Management | Asset Manager | Minority | ||
| Atlas Venture | Venture Capital | Minority | ||
| Avoro Capital | Venture Capital | Minority | ||
| Deerfield Management | Venture Capital | Minority | ||
| Deutsche Bank | Investment Bank | Minority |
Horizon Therapeutics Investments & Acquisitions (12)
Horizon Therapeutics’s most recent deal was a Corporate Asset Purchase with EirGen Pharma (Drug Product Manufacturing Facility in Waterford, Ireland) for . The deal was made on 01-Jul-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| EirGen Pharma (Drug Product Manufacturing Facility in Waterford, Ireland) | 01-Jul-2021 | Corporate Asset Purchase | Buildings and Property | ||
| Viela Bio | 15-Mar-2021 | Merger/Acquisition | Drug Discovery | ||
| Curzion Pharmaceuticals | 01-Apr-2020 | Merger/Acquisition | Biotechnology | ||
| Straight (Distributors (Healthcare)) | 26-Nov-2019 | Merger/Acquisition | Distributors (Healthcare) | ||
| River Vision | 08-May-2017 | Merger/Acquisition | Biotechnology |
Horizon Therapeutics ESG
Risk Overview
Risk Rating
Updated May, 30, 2024
17.22 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,120
Rank
Percentile
Pharmaceuticals
Industry
of 853
Rank
Percentile
Biotechnology
Subindustry
of 368
Rank
Percentile
Horizon Therapeutics Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Straight (Distributors (Healthcare)) | Vemars, France | 2018 |
Horizon Therapeutics FAQs
-
When was Horizon Therapeutics founded?
Horizon Therapeutics was founded in 2008.
-
Where is Horizon Therapeutics headquartered?
Horizon Therapeutics is headquartered in Dublin, Ireland.
-
What is the size of Horizon Therapeutics?
Horizon Therapeutics has 2,190 total employees.
-
What industry is Horizon Therapeutics in?
Horizon Therapeutics’s primary industry is Pharmaceuticals.
-
Is Horizon Therapeutics a private or public company?
Horizon Therapeutics is a Private company.
-
What is the current valuation of Horizon Therapeutics?
The current valuation of Horizon Therapeutics is .
-
What is Horizon Therapeutics’s current revenue?
The current revenue for Horizon Therapeutics is .
-
How much funding has Horizon Therapeutics raised over time?
Horizon Therapeutics has raised $1.78B.
-
Who are Horizon Therapeutics’s investors?
Athyrium Capital Management, Atlas Venture, Avoro Capital, Deerfield Management, and Deutsche Bank are 5 of 17 investors who have invested in Horizon Therapeutics.
-
Who are Horizon Therapeutics’s competitors?
Crinetics Pharmaceuticals, Santhera Pharmaceuticals, Merck & Co., Arcturus Therapeutics, and XBiotech are some of the 56 competitors of Horizon Therapeutics.
-
When was Horizon Therapeutics acquired?
Horizon Therapeutics was acquired on 06-Oct-2023.
-
Who acquired Horizon Therapeutics?
Horizon Therapeutics was acquired by Amgen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
